Clovis Oncology Inc (NASDAQ:CLVS)

48.36
Delayed Data
As of Apr 23
 -1.81 / -3.61%
Today’s Change
45.42
Today|||52-Week Range
99.45
-28.88%
Year-to-Date
No recent news for Clovis Oncology Inc.

Today’s Trading

Previous close50.17
Today’s open50.17
Day’s range47.51 - 50.85
Volume1,953,934
Average volume (3 months)1,336,450
Market cap$3.1B
Data as of 4:00pm ET, 04/23/2018

Growth & Valuation

Earnings growth (last year)+18.85%
Earnings growth (this year)+34.08%
Earnings growth (next 5 years)-93.11%
Revenue growth (last year)+71,067.95%
P/E ratioNM
Price/Sales57.63
Price/Book8.54

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...+1.39+4.18%
OPKOPKO Health Inc-0.07-2.27%
PBYIPuma Biotechnology I...+0.55+0.90%
MNKMallinckrodt Plc-0.69-5.01%
Data as of 4:00pm ET, 04/23/2018

Financials

Next reporting dateMay 8, 2018
EPS forecast (this quarter)-$1.26
Annual revenue (last year)$55.5M
Annual profit (last year)-$346.4M
Net profit margin-624.02%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
Principal Financial Officer &
SVP-Finance
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts